Exhaled leukotrienes and prostaglandins in COPD
Exhaled leukotrienes and prostaglandins in COPD
复制标题
DOI:
10.1136/thorax.58.7.585
复制
发表时间:
2003-07-01
期刊:
影响因子:
10
通讯作者:
Barnes, PJ
中科院分区:
文献类型:
--
作者:
Montuschi, P;Kharitonov, SA;Barnes, PJ
Background: The role of eicosanoids, including leukotrienes (LTs) and prostaglandins (PGs), in chronic obstructive pulmonary disease (COPD) is uncertain. The aim of this study was to investigate whether eicosanoids are measurable in exhaled breath condensate (EBC), a non-invasive method of collecting airway secretions, in patients with stable mild to moderate COPD, and to show possible differences in their concentrations compared with control subjects.Methods: LTB4, LTE4, PGE(2), PGD(2)-methoxime, PGF(2alpha), and thromboxane B-2 (TxB(2)) were measured in EBC in 15 healthy ex-smokers, 20 steroid naive patients with COPD who were ex-smokers, and in 25 patients with COPD who were ex-smokers and who were treated with inhaled corticosteroids. The study was of cross sectional design and all subjects were matched for age and smoking habit.Results: LTB4 and PGE(2) concentrations were increased in steroid naive (LTB4: median 100.6 (range 73.5-145.0) pg/ml, p